ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

‘Something positive for humankind’: Girls lend cells to genetic study – NBCNews.com

‘Something positive for humankind’: Girls lend cells to genetic studyNBCNews.comThe goal is the get the cells to misfire in the lab in just the same way they are in Hayley’s and Bari’s bodies. It’s a new marriage of genetics and stem cell research, and represents one of the most promising applications of so-called pluripotent stem … Continue reading

2013-12-08 Michael Zand NEWS

Novel drug regimen can improve stem cell transplantation outcomes – Medical Xpress

Novel drug regimen can improve stem cell transplantation outcomesMedical XpressAdding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers from Dana-Farber …Stem Cell Transplants can be improved by New Drug RegimenTopNews United States all 3 news articles …read … Continue reading

2013-12-08 Michael Zand NEWS

UCLA Researchers say Prostate Cancer Stem Cells are a Moving Target – Sierra Sun Times

UCLA Researchers say Prostate Cancer Stem Cells are a Moving TargetSierra Sun TimesDecemberr 3, 2013 – UCLA researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies. Following recent studies showing that prostate cancer … …read more   &nbs… Continue reading

2013-12-08 Michael Zand NEWS

Novel drug regimen can improve stem cell transplantation outcomes – EurekAlert (press release)

Novel drug regimen can improve stem cell transplantation outcomesEurekAlert (press release)NEW ORLEANS— Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers … and more …read more   &nbs… Continue reading

2013-12-08 Michael Zand NEWS

HIV Returns in Two Men Thought Cured After Stem Cell Transplant – Bloomberg

BloombergTwo HIV-infected men who were thought to be clear of the virus after having stem cell transplants have had the AIDS-causing pathogen return, their doctors said, scuppering hopes their cases might lead to a cure. The two Boston men, who were also …Two famously ‘cured’ Boston HIV sufferers are found to STILL have the virus … Continue reading

2013-12-07 Michael Zand NEWS

Human stem cells used to create lung tissue – DigitalJournal.com

DigitalJournal.comHuman stem cells have been converted into functioning lung cells for the first time. The objective behind the research was to create better models for studying lung diseases, ways to test potential drugs and, perhaps, the creation of tissue for lung …Scientists convert human stem cells into functional lung cellsGizmag all 3 news articles …read … Continue reading

2013-12-07 Michael Zand NEWS

Medical Council clears the air on stem cell research – Jamaica Gleaner

Medical Council clears the air on stem cell researchJamaica GleanerThe Medical Council has taken note of the discussion in the press regarding stem cell research. Council has also noted that Dr Janice Simmonds-Fisher, in her article published on December 4, 2013 in The Gleaner, has stated that the Medical Council of … …read more   &nbs… Continue reading

2013-12-07 Michael Zand NEWS

NASA, CASIS Make Space Station Accessible for Stem Cell Research – Space Ref (press release)

NASA, CASIS Make Space Station Accessible for Stem Cell ResearchSpace Ref (press release)NASA and the Center for the Advancement of Science in Space (CASIS) are enabling research aboard the International Space Station that could lead to new stem cell-based therapies for medical conditions faced on Earth and in space. Scientists will take … and more … Continue reading

2013-12-07 Michael Zand NEWS
  • 1
  • …
  • 3,372
  • 3,373
  • 3,374
  • 3,375
  • 3,376
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.